-  This bill is not active in this session.
 
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A06395 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         6395--B
 
                               2021-2022 Regular Sessions
 
                   IN ASSEMBLY
 
                                     March 17, 2021
                                       ___________
 
        Introduced  by M. of A. WOERNER, McDONALD, JONES, ASHBY, TAGUE, McMAHON,
          GRIFFIN, WALSH -- read once and referred to the Committee on  Alcohol-
          ism  and  Drug  Abuse  --  committee discharged, bill amended, ordered
          reprinted as amended and recommitted to said committee -- reported and
          referred to the Committee  on  Codes  --  committee  discharged,  bill
          amended,  ordered reprinted as amended and recommitted to said commit-
          tee
 
        AN ACT to amend the state finance law, the mental hygiene law,  and  the
          executive law, in relation to establishing an opioid settlement fund
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The state finance law is amended by adding  a  new  section
     2  99-nn to read as follows:
     3    § 99-nn. Opioid settlement fund. 1. There is hereby established in the
     4  joint  custody of the state comptroller and the commissioner of taxation
     5  and finance a special fund to be known as the "opioid settlement fund".
     6    2. Money allocated to the opioid settlement fund shall be  kept  sepa-
     7  rate  and shall not be commingled with any other funds in the custody of
     8  the state comptroller.
     9    3. Money expended from such fund shall be used to supplement  and  not
    10  supplant or replace any other funds, including federal or state funding,
    11  which  would  otherwise  have  been  expended for substance use disorder
    12  prevention, treatment, recovery or harm reduction services or  programs.
    13  Provided  further, general operating funds or baseline funding shall not
    14  be reduced due to monies expended from the fund.
    15    4. Such fund shall consist of money received by the state as a  result
    16  of  the  settlement of litigation with entities that manufactured, sold,
    17  distributed, dispensed or promoted  opioids,  made  in  connection  with
    18  claims  arising from the manufacturing, marketing, distributing, promot-
    19  ing or dispensing of opioids, as well as any funds received by the state
    20  as a result of a judgment, stipulation,  decree,  agreement  to  settle,
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10289-19-1

        A. 6395--B                          2
 
     1  assurance  of  discontinuance,  or  other legal instrument resolving any
     2  claim or cause of action against manufacturers, distributors, dispensers
     3  or vendors of opioids and related entities  arising  out  of  activities
     4  alleged  to  have  contributed to increases in opioid addiction, whether
     5  filed or unfiled, actual or potential, and whether arising under  common
     6  law, equity, or any provision of law, and all other monies appropriated,
     7  credited,  or transferred thereto from any other fund or source pursuant
     8  to law. All monies shall remain in such fund unless and  until  directed
     9  by statute or appropriation.
    10    5. Notwithstanding subdivision eleven of section four of this chapter,
    11  or  subdivision  sixteen  of  section  sixty-three of the executive law,
    12  monies from the opioid settlement  fund  shall  be  available  following
    13  appropriation  by the legislature and shall only be expended on eligible
    14  expenditures as defined in section 25.18 of the mental hygiene  law  for
    15  prevention,  treatment,  harm reduction and recovery services related to
    16  substance use disorders and co-occurring mental illnesses  in  New  York
    17  state  pursuant  to  the terms of the statewide opioid settlement agree-
    18  ments as defined in section 25.18 of the  mental  hygiene  law.  Funding
    19  shall  be  distributed  regionally  and  to  ensure  adequate geographic
    20  disbursement across the state in accordance with  the  statewide  opioid
    21  settlement  agreements. In addition to programs and services overseen by
    22  the office of addiction services and supports,    funding  may  also  be
    23  expended  on programs and services overseen by the department of health,
    24  the office of mental health,  the  division  of  housing  and  community
    25  renewal  or  any other agency that may oversee an appropriate program or
    26  service that is considered an eligible  expenditure  as  provided  under
    27  section 25.18 of the mental hygiene law. Funding decisions shall include
    28  an  emphasis  on supporting programs that are culturally, linguistically
    29  and gender competent, trauma-informed, evidence-based and, where  appro-
    30  priate, employ individuals with lived experience as part of the services
    31  provided.
    32    §  2.  The mental hygiene law is amended by adding a new section 25.18
    33  to read as follows:
    34  § 25.18 Statewide opioid settlements.
    35    (a) Definitions. As used in this section, the  following  terms  shall
    36  have  the  following  meanings:  1.  Eligible expenditures shall include
    37  services and programs that are consistent with  the  approved  uses  and
    38  terms  of  the statewide opioid settlement agreement and include but not
    39  be limited to, programs:
    40    (i) to prevent  substance  use  disorders  through  an  evidence-based
    41  youth-focused public health education and prevention campaign, including
    42  school-based  prevention and health care services and programs to reduce
    43  the risk of substance use by school-aged children;
    44    (ii) to develop and implement statewide public education campaigns  to
    45  reduce stigma against individuals with a substance use disorder, provide
    46  information  about  the  risks  of  substance  use,  best  practices for
    47  addressing substance use disorders, and information  on  how  to  locate
    48  services  that  reduce  the  adverse health consequences associated with
    49  substance use disorders or provide treatment for  substance  use  disor-
    50  ders;
    51    (iii)  to  provide substance use disorder treatment and early recovery
    52  programs for youth and adults, with an emphasis on programs that provide
    53  a continuum of care that includes screening and assessment for substance
    54  use disorders  and  co-occurring  disorders,  active  treatment,  family
    55  involvement,  case  management, relapse management for substance use and
    56  other co-occurring behavioral  health  disorders,  vocational  services,

        A. 6395--B                          3
 
     1  literacy  services,  parenting  classes,  family  therapy and counseling
     2  services, crisis services, recovery services, evidence-based treatments,
     3  medication-assisted treatments, including medication assisted  treatment
     4  provided in correctional facilities, psychiatric medication, psychother-
     5  apy and transitional services programs;
     6    (iv)  to  provide harm reduction counseling and services to reduce the
     7  adverse health consequences associated  with  substance  use  disorders,
     8  including  overdose  prevention  and prevention of communicable diseases
     9  related to substance use, provided by a substance use  disorder  service
    10  provider or qualified community-based organization;
    11    (v)  to  provide housing services for people who are recovering from a
    12  substance use disorder. Such  housing  services  shall  be  appropriate,
    13  based on the individual's current need and stage of recovery. Such hous-
    14  ing  services  may  include  but  are  not limited to supportive housing
    15  services;
    16    (vi) to support community-based programs that reduce the likelihood of
    17  criminal justice involvement for individuals who have or are at risk  of
    18  having a substance use disorder;
    19    (vii)  to  provide  programs  for  pregnant  women and new parents who
    20  currently or formerly have had a substance  use  disorder  and  newborns
    21  with neonatal abstinence syndrome; and
    22    (viii)  to provide vocational and educational training for individuals
    23  with or at risk for a substance use disorder.
    24    2. "Government entity" means  (i)  departments,  agencies,  divisions,
    25  boards,  commissions  and/or  instrumentalities of the state of New York
    26  including, the department of financial services, the  superintendent  of
    27  the  department  of  financial  services,  and  the New York liquidation
    28  bureau, provided however it shall not include the department of law; and
    29    (ii) any governmental subdivision within the boundaries of  the  state
    30  of  New  York,  including, but not limited to, counties, municipalities,
    31  districts, towns and/or villages, and any of their subdivisions, special
    32  districts and school districts, and any  department,  agency,  division,
    33  board, commission and/or instrumentality thereof.
    34    3.  "Participating entities" means participating entities as such term
    35  is defined in any statewide opioid settlement agreement.
    36    4. "Opioid settlement fund" means the fund created  by  the  statewide
    37  opioid  agreements  and section ninety-nine-nn of the state finance law,
    38  the funds of which shall be used or distributed by the commissioners, as
    39  authorized by the legislature  by  statute  or  appropriation,  for  the
    40  purposes  of  preventing  addiction and reducing the harms caused by the
    41  overdose and substance use disorder epidemic consistent with  the  terms
    42  of any statewide opioid settlement agreement.
    43    5.  "Released claims" means released claims as such term is defined in
    44  the statewide opioid settlement agreements.
    45    6. "Released entities" means released entities as such term is defined
    46  in the statewide opioid settlement agreements.
    47    7. "New York subdivisions" means each county, city, town, village,  or
    48  special district in the state of New York.
    49    8. "Statewide opioid settlement agreements" means agreements of state-
    50  wide  applicability,  including  but  not  limited to consent judgments,
    51  consent decrees filed or unfiled, and related  agreements  or  documents
    52  between  the  state  and  certain  opioid  manufacturers,  distributors,
    53  dispensers, consultants, chain pharmacies, related entities, and/or  the
    54  New  York  subdivisions,  to provide remuneration for conduct related to
    55  the manufacture, promotion, dispensing,  sale,  and/or  distribution  of
    56  opioid  products.  Copies  of  such agreements, including any amendments

        A. 6395--B                          4
 
     1  thereto, shall be kept on file by the attorney general, who  shall  make
     2  such  available for inspection and copying pursuant to the provisions of
     3  article six of the public officers law.
     4    (b) Eligible expenditures for opioid settlement funds. 1. The legisla-
     5  ture  shall  appropriate funds to be used for eligible expenditures that
     6  are consistent with the approved uses and terms of the statewide  opioid
     7  settlement agreement.  Such expenditures shall be distributed regionally
     8  and  in  accordance  with  the statewide opioid settlement agreements to
     9  ensure adequate geographic disbursement across the state.
    10    2. New York subdivisions shall apply to  the  appropriate  agency  for
    11  funding  for  eligible  expenditures  consistent  with  the terms of any
    12  statewide opioid settlement agreement.  Any New York  subdivision  which
    13  receives  funding pursuant to this section shall be required to annually
    14  certify to the appropriate state agency in which  funding  was  received
    15  that  such  New  York  subdivision is utilizing such funds in accordance
    16  with the requirements of this section and section ninety-nine-nn of  the
    17  state finance law.
    18    3.  Each  New  York subdivision shall provide a detailed accounting of
    19  how the funds were used as well as an analysis  and  evaluation  of  the
    20  services  and programs funded. Such information shall be included in the
    21  report provided pursuant to paragraph ten of  subdivision  (c)  of  this
    22  section.
    23    (c)  Advisory board establishment and responsibilities.  1. The opioid
    24  settlement board is hereby established under  the  office  of  addiction
    25  services and supports to provide recommendations on how funding received
    26  by  the opioid settlement fund pursuant to section ninety-nine-nn of the
    27  state finance law shall be allocated by the  legislature.    Recommenda-
    28  tions  shall be evidenced-based and may take into consideration federal,
    29  state or local initiatives and activities that have shown to  be  effec-
    30  tive in preventing and treating substance use disorders as well as main-
    31  taining  recovery and assisting with the collateral effects of substance
    32  use disorders for individuals and  their  families  or  support  system.
    33  Such  recommendations shall also take into account any gaps in access to
    34  services or programs identified as eligible expenditures and incorporate
    35  mechanisms for measurable outcomes for determining the effectiveness  of
    36  funds  expended.  The office and any other relevant agency that provides
    37  or regulates eligible expenditures shall provide  any  necessary  staff,
    38  resources  and  technical assistance to assist with the functions of the
    39  advisory board.   Such assistance shall  be  supported  pursuant  to  an
    40  appropriation  by  the  legislature,  in  accordance  with the statewide
    41  opioid settlement agreements.
    42    2. The opioid settlement board may make recommendations to the  legis-
    43  lature regarding the addition or removal of any eligible expenditures in
    44  response  to  changing  substance  use  disorder  needs in the state. No
    45  recommendation may be made to remove  an  eligible  expenditure  without
    46  three-fourths approval of present board members.
    47    3.  The  opioid  settlement  board  shall  consist of nineteen members
    48  appointed as follows:
    49    (i) the commissioner of addiction services and supports,  the  commis-
    50  sioner of mental health, and the commissioner of health, or their desig-
    51  nees, serving as ex-officio non-voting members;
    52    (ii) two appointments by the governor;
    53    (iii) two appointments by the temporary president of the senate;
    54    (iv) two appointments by the speaker of the assembly;
    55    (v) two appointments by the attorney general;
    56    (vi) one appointment by the mayor of the city of New York; and

        A. 6395--B                          5
 
     1    (vii)  seven  appointments from a list of nominees submitted, pursuant
     2  to a statewide opioid settlement agreement, by an association  of  coun-
     3  ties  that  represents  at  least  ninety percent of the counties in New
     4  York, counting both by number of counties and by population at the  time
     5  such statewide opioid settlement agreement was finalized.  Such appoint-
     6  ments shall be selected as follows:  two from the temporary president of
     7  the  senate, two from the speaker of the assembly, one from the minority
     8  leader of the senate, one from the minority leader of the  assembly  and
     9  one from the attorney general.
    10    4. Each member shall be appointed to serve three-year terms and in the
    11  event  of  a  vacancy,  the vacancy shall be filled in the manner of the
    12  original appointment for  the  remainder  of  the  term.  The  appointed
    13  members  and  commissioners  shall  receive  no  compensation  for their
    14  services but shall  be  allowed  their  actual  and  necessary  expenses
    15  incurred in the performance of their duties as board members.
    16    5.  Every effort shall be made to ensure a balanced and diverse board,
    17  representing the geographic regions and racial and  ethnic  demographics
    18  of  the state as well as those with lived experiences of a substance use
    19  disorder.   Appointed members shall have  an  expertise  in  public  and
    20  behavioral  health,  substance  use  disorder treatment, harm reduction,
    21  criminal justice, or drug policy. Further, the board shall include indi-
    22  viduals with personal or professional experience with substance use  and
    23  addiction  issues and co-occurring mental illnesses as well as providing
    24  services to those that have  been  disproportionately  impacted  by  the
    25  enforcement and criminalization of addiction.
    26    6.  The  chairperson  of  the  board and the vice chairperson shall be
    27  elected from among the members of the  board  by  the  members  of  such
    28  board.  The vice chairperson shall represent the board in the absence of
    29  the  chairperson  at  all  official  board  functions. A majority of the
    30  voting members of the board shall constitute a quorum.
    31    7. Members of the board shall not take any action  to  direct  funding
    32  from  the  opioid  settlement  fund to any entity in which they or their
    33  family members have any interest, direct or  indirect,  or  receive  any
    34  commission  or  profit  whatsoever,  direct  or indirect. Members of the
    35  board shall recuse themselves from any discussion or  vote  relating  to
    36  such interest.
    37    8.  The  board  shall  meet  quarterly,  to ensure recommendations are
    38  updated and consistent with the needs of the state.  Such meetings shall
    39  be held in accordance with article seven of the public officers law  and
    40  pursuant  to  the  federal  americans  with disabilities act of nineteen
    41  hundred ninety, as amended.
    42    9. On or before November first of each year, beginning November first,
    43  two thousand twenty-one, the board shall provide  their  recommendations
    44  for  how  such funds shall be appropriated, consistent with the require-
    45  ments of this section and section ninety-nine-nn of  the  state  finance
    46  law.   Such recommendations shall be provided in a written report to the
    47  governor, the temporary president of the  senate,  the  speaker  of  the
    48  assembly,  the  chair  of the senate finance committee, the chair of the
    49  assembly ways and means committee, the chair of  the  senate  alcoholism
    50  and  substance  abuse committee and the chair of the assembly alcoholism
    51  and drug abuse committee.
    52    10. On or before November first of each year, beginning one year after
    53  the initial deposit of monies in the opioid settlement fund,  the  rele-
    54  vant  commissioners,  in  consultation  with  the  advisory board, shall
    55  provide a written report to the governor,  temporary  president  of  the
    56  senate,  speaker of the assembly, chair of the senate finance committee,

        A. 6395--B                          6
 
     1  chair of the assembly ways and means  committee,  chair  of  the  senate
     2  alcoholism and substance abuse committee and chair of the assembly alco-
     3  holism  and  drug  abuse  committee. Such report shall be presented as a
     4  consolidated  dashboard and be made publicly available on the respective
     5  offices' websites. The report shall include the  following  information:
     6  (i)  the baseline  funding for any entity that receives funding from the
     7  opioid settlement fund, prior to the receipt of such  opioid  settlement
     8  funds;  (ii)  how funds deposited in the opioid settlement fund had been
     9  utilized in the preceding calendar year, including but not  limited  to:
    10  (A)  the  amount  of money disbursed from the fund and the award process
    11  used for such disbursement, if applicable; (B) the names of the  recipi-
    12  ents,  the  amounts  awarded  to  such  recipient  and details about the
    13  purpose such funds were awarded for, including  what  specific  services
    14  and  programs  the funds were used on and what populations such services
    15  or programs served; (C) the main  criteria  utilized  to  determine  the
    16  award,  including  how  the  program  or  service  assists to reduce the
    17  effects of substance use disorders; (D) an analysis of the effectiveness
    18  of the services and/or programs that received opioid settlement  funding
    19  in their efforts to reduce the effects of the overdose and substance use
    20  disorder  epidemic.   Such analysis shall utilize evidence-based uniform
    21  metrics when reviewing the effects the service  and/or  program  had  on
    22  prevention,  harm  reduction,  treatment, and recovery advancements; (E)
    23  any relevant information provided by the New York subdivisions  pursuant
    24  to  this  section;  and (F) any other information the commissioner deems
    25  necessary for the legislature to determine appropriate future awards and
    26  ensure such funding is not being  used  to  supplant  local,  state,  or
    27  federal funding.
    28    (d)  Limitation on authority of government entities to bring lawsuits.
    29  No government entity shall have the authority to assert released  claims
    30  against entities released by the department of law in a statewide opioid
    31  settlement  agreement executed by the department of law and the released
    32  party on or after June first, two thousand twenty-one. Any action  filed
    33  by  a  government  entity  after  June  thirtieth, two thousand nineteen
    34  asserting  released  claims  against  a  manufacturer,  distributor,  or
    35  dispenser  of  opioid products shall be extinguished by operation of law
    36  upon being released by the department of law in  such  statewide  opioid
    37  settlement agreement.
    38    §  3.  Section  19.07 of the mental hygiene law is amended by adding a
    39  new subdivision (n) to read as follows:
    40    (n) The office in consultation with the office of mental  health,  the
    41  department  of health, the division of housing and community renewal and
    42  any other agency that may oversee  an  appropriate  program  or  service
    43  shall  monitor and ensure funds appropriated pursuant to section ninety-
    44  nine-nn of the state finance law are expended for services and  programs
    45  in accordance with such section.
    46    §  4.  Paragraph  (b) of subdivision 16 of section 63 of the executive
    47  law, as added by section 4 of part HH of chapter 55 of the laws of 2014,
    48  is amended to read as follows:
    49    (b) Paragraph (a) of this subdivision shall not apply to any provision
    50  in the resolution of a claim or cause of action providing (1) moneys  to
    51  be  distributed  to the federal government, to a local government, or to
    52  any holder of a bond or other debt instrument issued by the  state,  any
    53  public  authority,  or  any public benefit corporation; (2) moneys to be
    54  distributed solely or exclusively as a payment of damages or restitution
    55  to individuals or entities that were specifically injured or  harmed  by
    56  the  defendant's or settling party's conduct and that are identified in,

        A. 6395--B                          7
 
     1  or can be identified by the terms  of,  the  relevant  judgment,  stipu-
     2  lation,  decree,  agreement  to  settle, assurance of discontinuance, or
     3  relevant instrument resolving the claim or cause of action;  (3)  moneys
     4  recovered or obtained by the attorney general where application of para-
     5  graph  (a)  of  this  subdivision is prohibited by federal law, rule, or
     6  regulation, or would result in the reduction or loss of federal funds or
     7  eligibility for federal benefits pursuant to federal law, rule, or regu-
     8  lation; (4) moneys recovered or obtained by or on  behalf  of  a  public
     9  authority,  a public benefit corporation, the department of taxation and
    10  finance, the workers' compensation board,  the  New  York  state  higher
    11  education  services corporation, the tobacco settlement financing corpo-
    12  ration, a state or local retirement system, an employee  health  benefit
    13  program  administered by the New York state department of civil service,
    14  the Title IV-D child support fund, the lottery prize fund, the abandoned
    15  property fund, or an endowment of the state university of  New  York  or
    16  any  unit  thereof  or any state agency, provided that all of the moneys
    17  received or recovered are immediately transferred to the relevant public
    18  authority, public benefit corporation,  department,  fund,  program,  or
    19  endowment;  (5)  moneys to be refunded to an individual or entity as (i)
    20  an overpayment of a tax, fine, penalty,  fee,  insurance  premium,  loan
    21  payment, charge or surcharge; (ii) a return of seized assets; or (iii) a
    22  payment  made  in  error; [and] (6) moneys to be used to prevent, abate,
    23  restore, mitigate or control any identifiable instance of prior or ongo-
    24  ing water, land or air pollution; and (7) moneys obtained as a result of
    25  a settlement agreement which resulted from litigation with entities that
    26  manufactured, sold, distributed, dispensed or promoted opioids  made  in
    27  connection  with  claims  arising  from  the  manufacturing,  marketing,
    28  distributing, promoting or dispensing of opioids, as well as  any  funds
    29  received  by  the state as a result of  a judgment, stipulation, decree,
    30  agreement to settle, assurance of discontinuance, or other legal instru-
    31  ment resolving any claim  or  cause  of  action  against  manufacturers,
    32  distributors,  dispensers  or  vendors  of  opioids and related entities
    33  arising out of activities alleged to  have  contributed to increases  in
    34  opioid  addiction,  whether  filed  or unfiled, actual or potential, and
    35  whether arising under common law, equity, or any provision of law.
    36    § 5. Paragraph (b) of subdivision 11 of section 4 of the state finance
    37  law, as added by section 1 of part HH of chapter 55 of the laws of 2014,
    38  is amended to read as follows:
    39    (b) Paragraph (a) of this subdivision shall not apply to (1) moneys to
    40  be distributed to the federal government, to a local government,  or  to
    41  any  holder  of a bond or other debt instrument issued by the state, any
    42  public authority, or any public benefit corporation; (2)  moneys  to  be
    43  distributed solely or exclusively as a payment of damages or restitution
    44  to  individuals  or entities that were specifically injured or harmed by
    45  the defendant's or settling party's conduct and that are identified  in,
    46  or  can  be identified by the terms of, the relevant judgment, agreement
    47  to settle, assurance of discontinuance, or relevant instrument resolving
    48  the claim or cause of action; (3) moneys  recovered  or  obtained  by  a
    49  state  agency  or  a state official or employee acting in their official
    50  capacity where application of  paragraph  (a)  of  this  subdivision  is
    51  prohibited  by  federal law, rule, or regulation, or would result in the
    52  reduction or loss of federal funds or eligibility for  federal  benefits
    53  pursuant  to  federal  law, rule, or regulation; (4) moneys recovered or
    54  obtained by or on behalf of a public authority, a public benefit  corpo-
    55  ration,  the  department  of  taxation and finance, the workers' compen-
    56  sation board, the New York state higher education services  corporation,

        A. 6395--B                          8
 
     1  the  tobacco  settlement financing corporation, a state or local retire-
     2  ment system, an employee health benefit program administered by the  New
     3  York  state  department  of  civil service, the Title IV-D child support
     4  fund,  the lottery prize fund, the abandoned property fund, or an endow-
     5  ment of the state university of New York or  any  unit  thereof  or  any
     6  state  agency, provided that all of the moneys received or recovered are
     7  immediately transferred to the relevant public authority, public benefit
     8  corporation, department, fund, program, or endowment; (5) moneys  to  be
     9  refunded  to  an  individual  or  entity as (i) an overpayment of a tax,
    10  fine,  penalty,  fee,  insurance  premium,  loan  payment,   charge   or
    11  surcharge;  (ii)  a  return of seized assets, or (iii) a payment made in
    12  error; [and] (6) moneys to be used to prevent, abate, restore, mitigate,
    13  or control any identifiable instance of prior or ongoing water, land  or
    14  air  pollution;  and  (7)  moneys  obtained  as a result of a settlement
    15  agreement which resulted from litigation  with  entities  that  manufac-
    16  tured,   sold,  distributed,  dispensed  or  promoted  opioids  made  in
    17  connection  with  claims  arising  from  the  manufacturing,  marketing,
    18  distributing,  promoting  or dispensing of opioids, as well as any funds
    19  received by the state as a result of  a judgment,  stipulation,  decree,
    20  agreement to settle, assurance of discontinuance, or other legal instru-
    21  ment  resolving  any  claim  or  cause  of action against manufacturers,
    22  distributors, dispensers or vendors  of  opioids  and  related  entities
    23  arising  out  of activities alleged to  have contributed to increases in
    24  opioid addiction, whether filed or unfiled,  actual  or  potential,  and
    25  whether arising under common law, equity, or any provision of law.
    26    § 6. This act shall take effect immediately.
Go to top